Central Hospital, Nancy, France: Communicable Diseases trials

The registry lists 10 Communicable Diseases studies with Central Hospital, Nancy, France as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prolonged Bed Rest Versus Early Raising in Vertebral OsteomyelitisEnrolling by invitationNCT04735081
• Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular RiskCompletedNCT05754879
• Evaluating Antibiotic Stewardship Assisted by Computer in the University Hospital of Nancy (MACABAO)Status unknownNCT04976829
• Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of Coronavirus Disease (COVID-19) PatientsCompletedNCT04629222
• Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care UnitCompletedNCT04528043
• Assessment of Diagnostic and Therapeutic Practices for Cardiac Implantable Electronic Devices Suspected Infections in Nancy University HospitalCompletedNCT04501835
• FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 ContextStatus unknownNCT04453540
• Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient SettingStatus unknownNCT03612297
• Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.Status unknownNCT03524014
• Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia ColiTerminatedNCT02474706Phase 4